Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...
Snake oil: a product that promises everything and delivers nothing. Are red light therapy and saunas in this class of ...
Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio ...
The experimental therapy is designed to activate the immune system's ability to not only recognize and destroy cancer cells, ...
UCSF research led to the world’s first immunotherapy to prevent type 1 diabetes. Now, scientists are aiming for the ‘holy ...
Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above ...
Immutep (IMM) stock soared 101% after FDA granted Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma. Market exclusivity & tax benefits await.
The pharma giant and medical device posts earnings and sales that beat analysts’ estimates.
FDA acceptance positions 18F-FET as a potential first-in-class US-approved amino acid PET agent for glioma characterization, addressing a major posttreatment imaging specificity gap.
All five patients in the trial received CS-101, a treatment developed by Chinese researchers, and achieved fast hematopoietic reconstruction. This process allows the body to restart its blood-making ...
In Southern California, some honeybees appear to be doing what many others across the country cannot: living with one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results